Todos os estudos
RecrutamentoFASE2INTERVENCIONISTA

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

The FARGO trial is a UK study exploring whether a 'healthy gut bacteria transplant' (Faecal Microbiota Transplant, or FMT) can benefit people with Primary Sclerosing Cholangitis (PSC) who also have Inflammatory Bowel Disease (IBD). PSC is a chronic liver condition without a cure, and many affected individuals also experience IBD. Research suggests an imbalance of gut bacteria might worsen these conditions. This trial aims to see if restoring this balance through FMT can reduce symptoms and improve quality of life. Participants will be randomly assigned to receive either the FMT treatment or a placebo (dummy treatment), with careful monitoring over 50 weeks. The study hopes to understand if FMT is an effective new approach for managing these conditions.

Em resumo

Status
Recrutamento
Fase
FASE2
Patrocinador
Universidade de Birmingham
Meta de inscrição
58
Iniciar
27 Mar 2024
Conclusão estimada
30 Set 2027

Sobre o que é este estudo?

The FARGO trial is an important UK research study looking into Primary Sclerosing Cholangitis (PSC), a long-term liver condition that currently has no medical treatment proven to slow its progress. Many people with PSC also develop Inflammatory Bowel Disease (IBD). Recently, scientists have noticed that people with both PSC and IBD often have an imbalance of the "good" and "bad" bacteria, viruses, and fungi in their gut, known as the gut microbiome. This imbalance is thought to play a role in developing and possibly worsening the liver problems seen in PSC.

This trial is investigating a treatment called Faecal Microbiota Transplant (FMT), sometimes called a 'healthy gut bacteria transplant'. The idea behind FMT is to restore a healthy balance of gut bacteria by introducing stool (poo) from a healthy donor into the gut of someone with PSC. If successful, it's hoped this could lead to fewer symptoms of both PSC and IBD, and ultimately improve a person's overall quality of life.

FMT involves carefully prepared stool collected from anonymous healthy donors who have undergone strict screening and testing to ensure it's as clean and safe as possible. While this might sound unusual, FMT has been safely used in other conditions like certain types of gut infections (Clostridioides difficile, or C. diff) and other inflammatory bowel conditions. The FARGO trial will involve 58 patients, where half will receive the FMT treatment and the other half a dummy treatment (placebo), to fairly compare the effects.

Pontos principais

  • The FARGO trial is investigating a new treatment (FMT) for PSC and IBD.
  • It aims to see if restoring gut bacteria balance can improve symptoms.
  • Half of participants will receive FMT, half a placebo, to compare effects.
  • The study involves regular visits over 50 weeks for assessments and monitoring.
  • FMT is prepared from carefully screened healthy donors and has shown a good safety record.
  • Taking part is voluntary, and you can withdraw at any time.

Quem pode ser elegível?

To join the FARGO trial, you would need to be at least 18 years old and capable of understanding what's involved. You must have a confirmed diagnosis of both Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD) that affects your colon. Your liver disease should be in an early to moderate stage, meaning there's some scarring but not advanced cirrhosis. We'd also look for certain blood test results related to your liver that are consistently above normal levels.

It's important that your IBD is not severely active at the time of screening, and you shouldn't have any signs of abnormal cell changes (dysplasia/neoplasia) in your colon. If you're already taking medications for your IBD or for PSC that overlaps with autoimmune hepatitis, these treatments need to have been at a stable dose for at least 12 weeks before joining the trial, and you should expect to stay on that same dose throughout the study. We won't be able to include individuals whose PSC is caused by other specific conditions, or if their IBD is very active.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Do you have a diagnosis of both Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD) that affects your colon?
  3. Is your PSC considered early to moderate stage (not advanced cirrhosis)?
  4. Are any medications you take for IBD or similar conditions at a stable dose for at least the last 12 weeks?
  5. Do you currently have a diagnosis of moderate to severe active IBD related symptoms?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to take part in the FARGO trial, your involvement will last for 50 weeks. This includes an initial 2-week 'screening' period to confirm you meet all the requirements. Following this, you would receive 8 treatments over 8 weeks. After your treatments, there will be follow-up appointments for up to 48 weeks.

During your time in the trial, you'll have several visits to either study centres or hospitals across England. These visits will involve discussions about your health history, blood tests, and stool tests. If you could become pregnant, you'll also have pregnancy tests. We'll review your current medications, assess specific measures related to your PSC and IBD, and ask you to complete questionnaires about your well-being. We'll also monitor any symptoms or side effects you might experience. For research purposes, additional blood, urine, stool, and colon tissue samples will be collected.

Riscos e benefícios potenciais

Taking part in any clinical trial involves both potential benefits and risks. You might benefit from the close medical attention you'll receive throughout the trial. If the FMT treatment proves effective, you could experience an improvement in your PSC and IBD symptoms and overall quality of life; however, there's no guarantee this will happen, especially as half of participants will receive a placebo. Potential risks are generally low with FMT, as it has a good safety record in other conditions, but side effects can occur, such as temporary digestive upset. All medical procedures carry some level of risk, which the study team will fully explain. You have the right to withdraw from the trial at any time, for any reason, without it affecting your usual medical care.

Localizações (5)

  • Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
    Código postal verificado
    Birmingham, Reino Unido· Recrutamento
  • St Mark's Hospital, London North West University Healthcare NHS Trust
    Código postal verificado
    Londres, Reino Unido· Recrutamento
  • Royal Free Hospital, Royal Free London NHS Foundation Trust
    Código postal verificado
    Londres, Reino Unido· Recrutamento
  • King's College Hospital, King's College Hospital NHS Foundation Trust
    Código postal verificado
    Londres, Reino Unido· Recrutamento
  • John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust
    Código postal verificado
    Oxford, Reino Unido· Recrutamento

Perguntas frequentes

What is Primary Sclerosing Cholangitis (PSC)?

PSC is a chronic liver disease where the bile ducts (tubes that carry bile from the liver) become inflamed and scarred, which can eventually damage the liver.

What is Inflammatory Bowel Disease (IBD)?

IBD is a term for conditions like Crohn's disease and ulcerative colitis, where parts of the digestive system become inflamed.

What is Faecal Microbiota Transplant (FMT)?

FMT involves gently introducing stool from a healthy donor into your gut to help restore a healthy balance of gut bacteria.

Will I know if I'm getting the real treatment or the dummy one?

No, this is a 'blinded' trial, meaning neither you nor your study doctor will know whether you are receiving the FMT or the placebo until the end of the study. This helps ensure fair results.

Posso sair do estudo a qualquer momento?

Yes, your participation is completely voluntary. You can decide to leave the study at any point, and your regular medical care will not be affected.

Como saber mais

Helen Coulthard

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "FAecal Microbiota Transplantation in primaRy sclerosinG chOl…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.